CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $697,937
- in 4 filings, $698K under 10b5-1 plans
Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-17 | POPS RICHARD F Director and CEO, Alkermes plc | Exercise or conversion | +8,750 | 735,236 | ||
| 2020-02-17 | POPS RICHARD F Director and CEO, Alkermes plc | Shares withheld for taxes | −3,886 | $17.77 | $69K | 731,350 |
| 2020-02-17 | POPS RICHARD F Director and CEO, Alkermes plc | Exercise or conversion · Restricted Stock Unit Award | −8,750 | 8,750 | ||
| 2020-02-17 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Exercise or conversion | +3,000 | 191,497 | ||
| 2020-02-17 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Exercise or conversion · Restricted Stock Unit Award | −3,000 | 3,000 | ||
| 2020-02-17 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Exercise or conversion | +2,500 | 53,253 | ||
| 2020-02-17 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −766 | $17.77 | $14K | 52,487 |
| 2020-02-17 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Exercise or conversion · Restricted Stock Unit Award | −2,500 | 2,500 | ||
| 2020-02-17 | FRATES JAMES M SVP, Alks Inc; CFO ALKS | Exercise or conversion | +3,000 | 63,459 | ||
| 2020-02-17 | FRATES JAMES M SVP, Alks Inc; CFO ALKS | Shares withheld for taxes | −904 | $17.77 | $16K | 62,555 |
| 2020-02-17 | FRATES JAMES M SVP, Alks Inc; CFO ALKS | Exercise or conversion · Restricted Stock Unit Award | −3,000 | 3,000 | ||
| 2020-02-17 | Brown Iain Michael SVP Finance & CAO, Alks Inc. | Exercise or conversion | +2,500 | 34,452 | ||
| 2020-02-17 | Brown Iain Michael SVP Finance & CAO, Alks Inc. | Shares withheld for taxes | −868 | $17.77 | $15K | 33,584 |
| 2020-02-17 | Brown Iain Michael SVP Finance & CAO, Alks Inc. | Exercise or conversion · Restricted Stock Unit Award | −2,500 | 2,500 | ||
| 2020-02-16 | POPS RICHARD F Director and CEO, Alkermes plc | Exercise or conversion | +18,125 | 734,558 | ||
| 2020-02-16 | POPS RICHARD F Director and CEO, Alkermes plc | Shares withheld for taxes | −8,072 | $17.77 | $143K | 726,486 |
| 2020-02-16 | POPS RICHARD F Director and CEO, Alkermes plc | Exercise or conversion · Restricted Stock Unit Award | −18,125 | 36,250 | ||
| 2020-02-16 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Exercise or conversion | +3,375 | 188,497 | ||
| 2020-02-16 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Exercise or conversion · Restricted Stock Unit Award | −3,375 | 6,750 | ||
| 2020-02-16 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Exercise or conversion | +3,375 | 10,252 |
Page 77 of 90 · 1,796 trades